Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 29:38:14520.
doi: 10.3389/ti.2025.14520. eCollection 2025.

Experimental Swine Models for Vascularized Composite Allotransplantation and Immunosuppression: A Systematic Review and Case Report of a Novel Heterotopic Hemifacial Swine Model

Affiliations
Review

Experimental Swine Models for Vascularized Composite Allotransplantation and Immunosuppression: A Systematic Review and Case Report of a Novel Heterotopic Hemifacial Swine Model

Leonard Knoedler et al. Transpl Int. .

Abstract

Lifelong immunosuppression is necessary to prevent rejection in vascularized composite allotransplantation (VCA). Animal models play a pivotal role in developing innovative immunosuppressive strategies. This systematic review and case report focuses on the most impactful swine VCA models while offering insights gained from the Yale Swine Allotransplantation Vascularized Experiment (Y-SAVE). 22 studies on swine VCA models were included. Key swine breeds included SLA-matched and mismatched MGH miniature swine, Yucatan miniature swine, and outbred domestic swine. Transplantation models varied, with 10 (45%) using osteomyocutaneous flaps and only 2 (9%) involving hemifacial flaps. While 16 (73%) studies utilized heterotopic models, 5 (23%) relied on orthotopic models. Novel strategies such as preconditioning and localized drug delivery emerged, alongside immunosuppression regimens combining tacrolimus with experimental therapies. We further introduced a modified heterotopic hemiface VCA model, demonstrating its feasibility for studying immune dynamics in facial transplants while preserving oral function and enabling serial skin and mucosal biopsies. Overall, our review highlights a notable gap in models that specifically investigate facial VCAs. Given the unique immunological environment of facial allografts, models such as the heterotopic hemiface transplant may offer critical insights into immune mechanisms and may provide a platform for refining targeted immunosuppressive strategies.

Keywords: graft rejection; immunosuppression; preclinical research; swine models; vascularized composite allotransplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
PRISMA 2020 Flowchart of the conducted methodology.
FIGURE 2
FIGURE 2
Hemifacial Heterotopic Transplant Model. (A) Outline of the hemifacial transplant. (B) Underside of the hemifacial graft after dissection, with an arrowhead marking the intraoral mucosa. (C) Demonstration of the vascular pedicle of the graft, with white vessel loop identifying the external jugular vein and red loops marking the common carotid artery. (D) Explanted hemifacial graft showing the vascular pedicle. (E) Dissected femoral vessels used for vascular anastomosis. (F) Hemifacial graft inset in the lateral abdominal wall post-transplantation.

Similar articles

References

    1. Kauke-Navarro M, Knoedler S, Panayi AC, Knoedler L, Haller B, Parikh N, et al. Correlation between Facial Vascularized Composite Allotransplantation Rejection and Laboratory Markers: Insights from a Retrospective Study of Eight Patients. J Plast Reconstr and Aesthet Surg (2023) 83:155–64. 10.1016/j.bjps.2023.04.050 - DOI - PubMed
    1. Kauke-Navarro M, Knoedler S, Panayi AC, Knoedler L, Noel OF, Pomahac B. Regulatory T Cells: Liquid and Living Precision Medicine for the Future of VCA. Transplantation (2023) 107(1):86–97. 10.1097/TP.0000000000004342 - DOI - PubMed
    1. Kauke M, Panayi AC, Safi AF, Haug V, Perry B, Kollar B, et al. Full Facial Retransplantation in a Female Patient-Technical, Immunologic, and Clinical Considerations. Am J Transpl (2021) 21(10):3472–80. 10.1111/ajt.16696 - DOI - PubMed
    1. Kauke M, Panayi AC, Tchiloemba B, Diehm YF, Haug V, Kollar B, et al. Face Transplantation in a Black Patient - Racial Considerations and Early Outcomes. N Engl J Med (2021) 384(11):1075–6. 10.1056/NEJMc2033961 - DOI - PMC - PubMed
    1. Huelsboemer L, Kauke-Navarro M, Boroumand S, Parikh N, Hosseini H, Yu CT, et al. Ten-Year Follow-Up after Face Transplantation-A Single-Center Retrospective Cohort Study. Am J Transpl (2024) 25:611–22. 10.1016/j.ajt.2024.10.007 - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources